Risk of miscarriage among users of corticosteroid hormones: A population-based nested case-control study

Clinical Epidemiology

Volumn 5, Issue 1, 2013, Pages 287-294

  Bjørn, Anne Mette B ^a   Nielsen, Rikke B ^a   Nørgaard, Mette ^a   Nohr, Ellen A ^a   Ehrenstein, Vera ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Case control study; Corticosteroid hormones; Epidemiology; Miscarriage

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DRUG USE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION;

EID: 84881627348     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S46893     Document Type: Article

References (48)

1. Chrousos G. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung B, editor. Basic and Clinical Pharmacology. 10th edition. New York, NY: McGraw-Hill Companies Inc; 2007.
2. Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from National Health Surveys. Ann Epidemiol. 2003;13: 317-324.
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
4. Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197:585. e1-e7.
5. McGee DC. Steroid use during pregnancy. J Perinat Neonatal Nurs. 2002;16:26-39.
6. Bay Bjørn AM, Ehrenstein V, Hundborg HH, Nohr EA, Sørensen HT, Nørgaard M. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. September 24, 2012. [Epub ahead of print.]
7. Savitz DA, Hertz-Picciotto I, Poole C, Olshan AF. Epidemiological measures of the course and outcome of pregnancy. Epidemiol Rev. 2002;24:91-101.
8. Silverman M, Sheffer A, Diaz PV, et al. Outcome of pregnancy in randomized controlled study of patients with asthma exposed to budesonide. Ann Allergy Asthma Immunol. 2005;95:566-570.
9. Tata LJ, Lewis SA, McKeever TM, et al. A comprehensive analysis of adverse obstetric and pediatric complications in women with asthma. Am J Respir Care Med. 2007;175:991-997.
10. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18:93-101.
11. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62: 385-392.
12. The National Board of Health. Online data. Available from: http://www.sst.dk/Udgivelser/2012/Foedselsstatistikken%202011.aspx. Accessed June 6, 2013. Danish.
13. Ministry of Health and Prevention. Report: Health Care in Denmark, 2008. Available from: http://www.sum.dk/Aktuelt/Publikationer/Publikationer/UK_Healthcare_in_DK.aspx. Accessed June 6, 2013. Danish.
14. Pedersen C, Gotzsche H, Moller J, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449.
15. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
16. Jørgensen FS. Organization of obstetric ultrasound in Denmark 2000 - with description of the development since 1990. Dan Med Bull. 2003;165:4404-4409.
17. Kristensen J, Langhoff-Ross, Theil Skovgaard L, Børlum Kristensen F. Validation of the Danish birth registration. J Clin Epidemiol. 1996;49: 893-897.
18. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol. 2010;2:273-279.
19. Cundy T, Gamble G, Neale L, et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care. 2007;30:2603-2607.
20. Pittschieler S, Brezinka C, Jahn B, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol. 2008;255: 1926-1931.
21. Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322:266-270.
22. Brown S. Miscarriage and its associations. Semin Reprod Med. 2008;26: 391-400.
23. Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol. 1998;92:435-440.
24. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet. 1999;86:242-244.
25. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997;56: 335-340.
26. Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183:796-804.
27. Källén B, Olausson PO. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol. 2007;63: 383-388.
28. Pradat P, Robert-Gnansia E, Di Tanna GC, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67:968-970.
29. Rodríguez-Pinilla E, Martínez-Frías M. Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology. 1998;58:2-5.
30. Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar L, Petitti D. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997;100:301-306.
31. Rothman K. Measuring disease occurrence and causal effect. In: Rothman K, editor. Epidemiology - An Introduction. New York, NY: Oxford University Press Inc; 2002.
32. Weinberg CR, Wilcox AJ. Methodologic issues in reproductive epidemiology. In: Rothman K, Greenland S, Lash T, editors. Modern Epidemiology. Philadelphia, PA: Lippincott Williams and Wilkins; 2008.
33. Mellor A, Munn D. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol. 2000;18: 367-391.
34. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med. 1997;337:148-154.
35. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriages. Cochrane Database Syst Review. 2006;2:CD000122.
36. Salmon JE. A noninflammatory pathway for pregnancy loss: innate immune activation? J Clin Invest. 2004;114:15-17.
37. Csizmadi I, Collet JP, Boivin JF. Bias and confounding in pharmacoepidemiology. In: a. trom B, editor. Pharmacoepidemiology. 5th ed. West Sussex, UK: John Wiley and Sons Ltd; 2005.
38. Dombrowski MP. Asthma and pregnancy. Obstet Gynecol. 2006;108: 667-681.
39. Schatz M. Asthma and pregnancy. Lancet. 1999;353:1202-1204.
40. Ehrenstein V, Sørensen HT, Bakketeig LS, Pedersen L. Medical databases in studies of drug teratogenicity: methodological issues. Clin Epidemiol. 2010;2:37-43.
41. Michael AE, Papageorghiou AT. Potential significance of physiological and pharmacological glucocorticoids in early pregnancy. Hum Reprod Update. 2008;14:497-517.
42. Lohse SR, Farkas DK, Lohse N, et al. Validation of spontaneous abortion diagnoses in the Danish National Registry of Patients. Clin Epidemiol. 2010;2:247-250.
43. Buss L, Tolstrup J, Munk C, et al. Spontaneous abortion: a prospective cohort study of younger women from the general population in Denmark. Validation, occurrence and risk determinants. Acta Obstet Gynecol Scand. 2006;85:467-475.
44. Rothman KJ. Bias in study design. In: Rothman K., editor. Epidemiology - An Introduction. New York, NY: Oxford University Press; 2002.
45. Cupul-Uicab LA, Baird DD, Skjaerven R, Saha-Chaudhuri P, Haug K, Longnecker MP. In utero exposure to maternal smoking and women's risk of fetal loss in the Norwegian Mother and Child Cohort (MoBa). Hum Reprod. 2011;26:458-465.
46. Ness RB, Grisso JA, Hirschinger N, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med. 1999;340:333-339.
47. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;340:333-339.
48. Rey E, Boulet LP. Pregnancy plus: asthma in pregnancy. BMJ. 2007;334:582-585.